eXoZymes reports 535g NCT pilot run at 99% conversion, 90% yield, 99.6% purity

EXOZYMES INC.

Achieved ~99% reaction conversion, 90% isolated yield, and 535 g of NCT at 99.6% pharma-grade purity from a 100L pilot run.
Production executed externally by Cayman Chemical, demonstrating protocol transferability and operational robustness.
High-purity NCT is now available for formulation development and partner sample requests.
Company expects 2026 focus on commercial NCT supply chain, expanded volumes, and strategic partnerships.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.